Gene editing lowered blood level cholesterol and triglycerides in monkeys
New York Times - 27-Jun-2020Could prevent not only the complications but the heart disease per se in the future
Join the club for FREE to access the whole archive and other member benefits.
Professor, Director of the Lipid Clinic, The University of Chicago
Michael H. Davidson, MD, is a nationally recognized expert on statins, novel lipid-lowering drugs and the reduction of coronary artery disease risk through diet and exercise. He specializes in heart disease prevention, teaching patients to take a proactive approach in managing cardiac risk factors.
An active researcher, Dr. Davidson’s clinical research background encompasses both pharmaceutical and nutritional clinical trials. His extensive research on statins, novel lipid-lowering drugs, and nonpharmacologic risk factor reduction has established him as a key opinion leader in this area.
A prolific author and lecturer on lipid disorders, nutrition, and atherosclerosis, Dr. Davidson has coordinated more than 1,000 clinical trials in areas of preventive cardiology. He has published more than 250 articles for leading medical journals and has written several books on lipidology.
Dr. Davidson has been named one of "The Best Doctors in America" by Best Doctors Inc. for the past 10 years and was named Father of the Year by the American Diabetes Association, 2010. He has served as the president of the National Lipid Association.
Visit website: https://www.uchicagomedicine.org/find-a-physician/physician/michael-h-davidson
See also: The University of Chicago - Public Research university.
Details last updated 29-Jun-2020
Could prevent not only the complications but the heart disease per se in the future